Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Boston and Johnson & Johnson thwarted in legal clash over DESs (Drug-eluting stents)

This article was originally published in Clinica

Executive Summary

Drug-eluting stent rivals Boston Scientific and Johnson & Johnson have both been thwarted in their latest courtroom clash. The judgement, delivered late last week, has no immediately negative impact on the two companies, but J&J has come out of this confrontation with greater hope of striking its rival a blow in the next.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065374

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel